Equillium, Inc.
EQNasdaq
$2.59
↑ +3.6%Jul 17 close · end-of-day
Price
1Y↑ +524.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$249.4M
Enterprise Value
$188.0M
P/E
—
P/S
—
P/B
4.2
EV/EBITDA
—
PEG
—
FCF Yield
-7.6%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$19.1M
Free Cash Flow (TTM)
-$18.9M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-32.0%
ROIC
—
Debt / Equity
—
Net Cash
$61.3M
Return 1Y
+515.2%
Company profile
Equillium, Inc. develops and sells products to treat severe autoimmune and inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6.
- CEO
- Bruce D. Steel
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 40
- Headquarters
- California
- Website
- equilliumbio.com
Management & directors
- Connelly StephenPresident and CSO
- Zedelmayer ChristineSr. Vice President and COO
- Tom PennyPrincipal Accounting Officer
Roles derived from SEC Form 4 filings.
Earnings
EQ Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.06↓ -75.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $15.8M | $36.1M | $41.1M | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$29.5M | -$37.8M | -$62.1M | -$14.5M | -$8.3M | -$23.6M |
| Net income | -$29.8M | -$39.1M | -$62.4M | -$13.3M | -$8.1M | -$22.4M |
| Diluted EPS | — | -$1.36 | -$1.85 | -$0.38 | -$0.23 | -$0.39 |
| Operating cash flow | -$24.6M | -$32.1M | -$8.7M | -$21.8M | -$19.0M | -$22.7M |
| Free cash flow | -$24.8M | -$32.1M | -$9.0M | -$21.8M | -$19.1M | -$22.8M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | -393.9% | -40.2% | -20.1% | — |
| Net margin | — | — | -396.1% | -37.0% | -19.6% | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.9M | $12.2M | $4.4M | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$100,000.00 | -$679,000.00 | -$4.7M | -$8.9M | -$6.2M | -$4.6M | -$4.0M | -$5.6M |
| Net income | $468,000.00 | -$7,000.00 | -$5.8M | -$8.7M | -$5.7M | -$4.2M | -$3.8M | -$5.3M |
| Diluted EPS | $0.01 | $0.00 | -$0.16 | -$0.24 | -$0.16 | -$0.06 | $0.07 | -$0.06 |
| Operating cash flow | $730,000.00 | -$7.7M | -$3.3M | -$8.2M | -$3.0M | -$8.4M | -$3.1M | -$4.3M |
| Free cash flow | $668,000.00 | -$7.7M | -$3.3M | -$8.2M | -$3.0M | -$8.4M | -$3.2M | -$4.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -0.7% | -5.6% | -107.0% | — | — | — | — | — |
| Net margin | 3.4% | -0.1% | -131.9% | — | — | — | — | — |
Company news
Jun 10, 2026
Jun 2, 2026
May 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-05 | Connelly Stephen· President and CSO | Sale | 30,975 | $2.94 | $91,069.60 | filing |
| 2026-06-05 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 14,584 | $2.93 | $42,736.95 | filing |
| 2026-06-05 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 14,584 | $0.79 | $11,448.44 | filing |
| 2026-06-04 | Connelly Stephen· President and CSO | Sale | 200,000 | $3.16 | $632,760.00 | filing |
| 2026-05-28 | Tom Penny· Principal Accounting Officer | Sale | 65,000 | $2.95 | $191,750.00 | filing |
| 2026-05-28 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 55,604 | $2.70 | $150,130.80 | filing |
| 2026-05-28 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 30,208 | $2.98 | $90,019.84 | filing |
| 2026-05-28 | Tom Penny· Principal Accounting Officer | Option exercise | 65,000 | $0.79 | $51,025.00 | filing |
| 2026-05-28 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 48,512 | $0.77 | $37,354.24 | filing |
| 2026-05-28 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 15,625 | $0.79 | $12,265.63 | filing |
| 2026-05-28 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 14,583 | $0.79 | $11,447.66 | filing |
| 2026-05-28 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 7,292 | $0.73 | $5,323.16 | filing |
| 2026-05-28 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 200 | $2.71 | $542.00 | filing |
| 2026-05-27 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 9,821 | $2.70 | $26,516.70 | filing |
| 2026-05-27 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 9,821 | $0.77 | $7,562.17 | filing |
| 2026-03-13 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 120,312 | $2.50 | $300,816.09 | filing |
| 2026-03-13 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 120,312 | $0.79 | $94,444.92 | filing |
| 2026-03-09 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 181,219 | $2.00 | $362,438.00 | filing |
| 2026-03-09 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 75,000 | $0.79 | $58,875.00 | filing |
| 2026-03-09 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 41,666 | $0.79 | $32,707.81 | filing |
| 2026-03-09 | Zedelmayer Christine· Sr. Vice President and COO | Option exercise | 35,695 | $0.79 | $28,020.58 | filing |
| 2026-02-19 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 109,375 | $1.78 | $194,840.63 | filing |
| 2026-02-19 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 109,375 | $1.78 | $194,840.63 | filing |
| 2026-02-19 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 76,562 | $1.74 | $133,263.82 | filing |
| 2026-02-19 | Zedelmayer Christine· Sr. Vice President and COO | Sale | 76,562 | $1.74 | $133,263.82 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.